These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9107617)

  • 1. An experimental test of a theoretical foundation for rating-scale valuations.
    Bleichrodt H; Johannesson M
    Med Decis Making; 1997; 17(2):208-16. PubMed ID: 9107617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient utilities in fibromyalgia and the association with other outcome measures.
    Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a case for using visual analogue scale valuations in cost-utility analysis?
    Parkin D; Devlin N
    Health Econ; 2006 Jul; 15(7):653-64. PubMed ID: 16498700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
    Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
    Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the equivalence of collectively and individually collected responses: standard-gamble and time-tradeoff judgments of health states.
    Krabbe PF; Essink-Bot ML; Bonsel GJ
    Med Decis Making; 1996; 16(2):120-32. PubMed ID: 8778530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia.
    Bakker C; Rutten M; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1994 Feb; 21(2):269-74. PubMed ID: 8182636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient utilities in ankylosing spondylitis and the association with other outcome measures.
    Bakker C; Rutten-van Mölken M; Hidding A; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1994 Jul; 21(7):1298-304. PubMed ID: 7966073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A psychometric analysis of the measurement level of the rating scale, time trade-off, and standard gamble.
    Cook KF; Ashton CM; Byrne MM; Brody B; Geraci J; Giesler RB; Hanita M; Souchek J; Wray NP
    Soc Sci Med; 2001 Nov; 53(10):1275-85. PubMed ID: 11676400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The construction of standard gamble utilities.
    van Osch SM; Stiggelbout AM
    Health Econ; 2008 Jan; 17(1):31-40. PubMed ID: 17410521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).
    Brunner HI; Maker D; Grundland B; Young NL; Blanchette V; Stain AM; Feldman BM
    Med Decis Making; 2003; 23(4):314-22. PubMed ID: 12926581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values.
    Dolan P; Sutton M
    Soc Sci Med; 1997 May; 44(10):1519-30. PubMed ID: 9160441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs.
    Bleichrodt H; Johannesson M
    J Health Econ; 1997 Apr; 16(2):155-75. PubMed ID: 10169092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valuing the health state 'tinnitus': differences between patients and the general public.
    Happich M; von Lengerke T
    Hear Res; 2005 Sep; 207(1-2):50-8. PubMed ID: 15919164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of QALYs: an experimental test of constant proportional tradeoff and utility independence.
    Bleichrodt H; Johannesson M
    Med Decis Making; 1997; 17(1):21-32. PubMed ID: 8994148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities.
    Peeters Y; Stiggelbout AM
    Value Health; 2010; 13(2):306-9. PubMed ID: 19744288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of dental health state utilities.
    Fyffe HE; Kay EJ
    Community Dent Oral Epidemiol; 1992 Oct; 20(5):269-73. PubMed ID: 1424546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
    Dolan P; Stalmeier P
    J Health Econ; 2003 May; 22(3):445-58. PubMed ID: 12683961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.